OPTI itself has always been a company that, as an outsider, I cannot see for the life in me why people have been or remained invested for the past three or four years. There are so many alarm bells that I have often read your articles and thought how I’m glad I’m not invested there, and how sorry I feel for investors that are trapped underwater. I understand it once showed good promise, but the repeated lack of meaningful achievement in the core business is worrying. Running on the fuel of share sales to keep the lights on is a slow, painful unfolding disaster for those that do loyally hold.
You're absolutely right, I believe there's a lot of long term investors (myself included) who invested back when the biome sector looked ground breaking and with OPTI specifically, it had:
- LP-LDL
- Slimbiome
- Leanbiome, Wellbiome etc
- Skinbiotix Technology
- Sweetbiotix (probably the largest draw for most)
- Microbiome Modulators
There were regular RNS announcement of deals being done, that if only a handful come good could be worth 250K, 500K etc. Phrases like competitive tension etc.
One good thing SOH did was setting up SBTX as separate company. We needed cash to move that forward and it's been a lifesaver in preventing OPTI shareholder being diluted.
I was very much against PBX though, LP-LDL was what was providing us revenue and would have helped the share price stay higher and help us reach break-even quicker. Instead we got a divi, that when we could actually sell it, was only worth a fraction of the loss in OPTI share price. I still do not to this day understand why SOH though listing PBX and esp on Aquiss was a good idea.
I do believe the recent misleading with sweetbiotix commercialisation and recent fundraise while being told Morepen are doing great, the USA is doing great has made me and many others totally lose trust in SOH and his ability. I hope we are proven wrong though.
It is unfortunate this has happened, and hope that things can settle down and everyone can have a cordial relationship going forward.
I'm extremely disappointed in SOH, I genuinely believed 2024 was going to be the year of the Sweetbiotix commercialisation, and all the information SOH provided led to that impression. To find it no further than we were a few years ago is frustrating and basically have NO news about it in 2025 is ridiculous. The recent selling of SBTX and raise was not great.
I do believe SOH does try to protect share-holder value, but the 8 years I have held shares, we are nowhere near where we should be.
Surely SOH wants to get Sweetbiotix commercialised in his lifetime, really do not understand the delay after delay, unless PJ theory is true.
I hope you will continue to feature OPTI, as both OPTI and SBTX are the main reasons I subscribe to Lemming Investor service and believe you still have a large readership who are still invested in OPTI.
Brave and honest post thank you for producing. I’m a bit surprised that it’s actually taken this long to see the company and the actions of SOH for what it is. It’s still worth something , mainly for the shares in other companies it holds. SOH in forming the initial companies did have flashes of brilliance to be fair, but as to getting deals done and successfully running with decent income a total failure. These literally dozens of deals have all failed so must be a more common reason why and Opti shareholders have a right to know. Clearly it’s time for SOH to retire and hand over the job to another. His failures to achieve financial breakthrough with all those deals has also seriously damaged SBTX, as SOH has been steadily selling nearly 20M shares over the last 4 years and doesn’t seem like stopping soon. Clearly to give an apology just to find out you were right all the time leaves a rancid taste in the mouth. However SOH does still have a lot of firepower at his disposal, and although you might not like it I would suggest that you try to tread lightly, to avoid being the target rightly or wrongly of something stronger. Indeed I wouldn’t put it past him if backed into a corner for him to flood the market with loads of Sbtx stock out of spite, knowing that you and most of your readership also support Sbtx, and a way of seriously hurting your relationships there. He could easily dress it up as SF one thing else, like the promised Divi payment to opti holders. So although I applaud your articles please be careful when dealing with someone who’s irrational.
Unfortunately SOH is not really ceo material. He has been able to play at being one through constantly selling skin shares to cover the fact it's a nothing company being badly run. I still believe he has issues with SA great work (tbc) and willingly sells to surpres our sp. Weak little man.
Regrettably our worst fears seem to be playing out in the public domain.
I cannot see how the Board at OPTI can turn this into a positive without engaging with sCC or Shareprophets ( or both) at some point. If that is the existing BoD or a new one remains to be seen.
The only other saving grace for OPTI is if a big contract or need flow materialises unexpectedly, but given we have been waiting 12 years for such the the chances are next to zero I would have thought.
Meanwhile, as it becomes apparent OPTI has been run fur the primary benefit of the Directors rather than shareholders, I wonder what quieries and untruths may unfold regarding the currently invisible Sweetbiotix where not even one photograph of the product exists to support its existence. It seems blatantly obvious what OPTI needs to showcase at the AGM, when they can be bothered to action it, and actually have some samples.
Its been scary how correct you have been with your views, especially around sweetbiotix. I'm astonished a ceo would behave as he has and not expect it to come back and bite. Is soh going through a Biden period? Is the chair running the company?
I don't anyone with eyes can conclude you guys have reported accurately and not allowed the sponsorship to sway you. Its soh integrity thats questionable.
Absolutely spot on — your analysis couldn't be more incisive. Rebuilding credibility in the markets is a Herculean task at the best of times, but when there's compelling evidence of "serial lies and deception," it becomes practically insurmountable. Trust, once shattered, rarely glues back together cleanly — especially not under the stewardship of a CEO who seems, at best, to be making strategic decisions with the acuity of a distracted raccoon.
Choosing to turn on ShareProphets and Lemming Investor — both of whom, despite their occasionally acerbic style, have proven themselves to offer far more balanced and well-researched commentary than anything issuing from the company’s own press releases — is not just counterproductive, it borders on the delusional. It’s a move so misjudged it suggests either panicked deflection or outright incompetence. Either way, the Board's silence only amplifies the growing suspicion that they're running from engagement because they can't withstand scrutiny.
Frankly, if OPTI has any hope of dragging itself out of this mire, meaningful engagement with sceptical voices like ShareProphets or Lemming Investor isn’t optional — it’s essential. Whether it’s the current crop of directors or a completely new broom remains to be seen, but what’s certain is the current approach leads nowhere good.
As for that perennial carrot — the "big contract" that’s supposedly always just around the corner — forgive the cynicism, but 12 years of vapid promises have diluted that hope to homeopathic levels. It's bordering on absurd.
And yes, the Sweetbiotix saga — a supposedly flagship product with not so much as a photograph to prove it exists. No samples, no real-world application, no substantiating detail. If the company can’t even muster the PR basics to showcase a physical product, then what exactly are they doing? The AGM — if and when it ever appears — needs to be less about slides and slogans, and more about receipts and results.
Gentlemen, please be respectful to each member. We will not permit personal attacks to be posted in these threads. Please keep on topic.
I have removed two posts. We do not wish to censor anyone. However, we are not going to allow these threads to reflect the behaviour on ADFN or LSE.
Please show respect.
Thanks for censoring those posts Alex.
OPTI itself has always been a company that, as an outsider, I cannot see for the life in me why people have been or remained invested for the past three or four years. There are so many alarm bells that I have often read your articles and thought how I’m glad I’m not invested there, and how sorry I feel for investors that are trapped underwater. I understand it once showed good promise, but the repeated lack of meaningful achievement in the core business is worrying. Running on the fuel of share sales to keep the lights on is a slow, painful unfolding disaster for those that do loyally hold.
You're absolutely right, I believe there's a lot of long term investors (myself included) who invested back when the biome sector looked ground breaking and with OPTI specifically, it had:
- LP-LDL
- Slimbiome
- Leanbiome, Wellbiome etc
- Skinbiotix Technology
- Sweetbiotix (probably the largest draw for most)
- Microbiome Modulators
There were regular RNS announcement of deals being done, that if only a handful come good could be worth 250K, 500K etc. Phrases like competitive tension etc.
One good thing SOH did was setting up SBTX as separate company. We needed cash to move that forward and it's been a lifesaver in preventing OPTI shareholder being diluted.
I was very much against PBX though, LP-LDL was what was providing us revenue and would have helped the share price stay higher and help us reach break-even quicker. Instead we got a divi, that when we could actually sell it, was only worth a fraction of the loss in OPTI share price. I still do not to this day understand why SOH though listing PBX and esp on Aquiss was a good idea.
I do believe the recent misleading with sweetbiotix commercialisation and recent fundraise while being told Morepen are doing great, the USA is doing great has made me and many others totally lose trust in SOH and his ability. I hope we are proven wrong though.
It is unfortunate this has happened, and hope that things can settle down and everyone can have a cordial relationship going forward.
I'm extremely disappointed in SOH, I genuinely believed 2024 was going to be the year of the Sweetbiotix commercialisation, and all the information SOH provided led to that impression. To find it no further than we were a few years ago is frustrating and basically have NO news about it in 2025 is ridiculous. The recent selling of SBTX and raise was not great.
I do believe SOH does try to protect share-holder value, but the 8 years I have held shares, we are nowhere near where we should be.
Surely SOH wants to get Sweetbiotix commercialised in his lifetime, really do not understand the delay after delay, unless PJ theory is true.
I hope you will continue to feature OPTI, as both OPTI and SBTX are the main reasons I subscribe to Lemming Investor service and believe you still have a large readership who are still invested in OPTI.
Brave and honest post thank you for producing. I’m a bit surprised that it’s actually taken this long to see the company and the actions of SOH for what it is. It’s still worth something , mainly for the shares in other companies it holds. SOH in forming the initial companies did have flashes of brilliance to be fair, but as to getting deals done and successfully running with decent income a total failure. These literally dozens of deals have all failed so must be a more common reason why and Opti shareholders have a right to know. Clearly it’s time for SOH to retire and hand over the job to another. His failures to achieve financial breakthrough with all those deals has also seriously damaged SBTX, as SOH has been steadily selling nearly 20M shares over the last 4 years and doesn’t seem like stopping soon. Clearly to give an apology just to find out you were right all the time leaves a rancid taste in the mouth. However SOH does still have a lot of firepower at his disposal, and although you might not like it I would suggest that you try to tread lightly, to avoid being the target rightly or wrongly of something stronger. Indeed I wouldn’t put it past him if backed into a corner for him to flood the market with loads of Sbtx stock out of spite, knowing that you and most of your readership also support Sbtx, and a way of seriously hurting your relationships there. He could easily dress it up as SF one thing else, like the promised Divi payment to opti holders. So although I applaud your articles please be careful when dealing with someone who’s irrational.
Completely lost the plot, don't know why anybody is invested in OPTI.
Unfortunately SOH is not really ceo material. He has been able to play at being one through constantly selling skin shares to cover the fact it's a nothing company being badly run. I still believe he has issues with SA great work (tbc) and willingly sells to surpres our sp. Weak little man.
Regrettably our worst fears seem to be playing out in the public domain.
I cannot see how the Board at OPTI can turn this into a positive without engaging with sCC or Shareprophets ( or both) at some point. If that is the existing BoD or a new one remains to be seen.
The only other saving grace for OPTI is if a big contract or need flow materialises unexpectedly, but given we have been waiting 12 years for such the the chances are next to zero I would have thought.
Meanwhile, as it becomes apparent OPTI has been run fur the primary benefit of the Directors rather than shareholders, I wonder what quieries and untruths may unfold regarding the currently invisible Sweetbiotix where not even one photograph of the product exists to support its existence. It seems blatantly obvious what OPTI needs to showcase at the AGM, when they can be bothered to action it, and actually have some samples.
I’m pretty sure I’m correct in recalling that even OPTi own broker didn’t have a buy recommendation on it?
Probably have cross their palms with gold, or juice from a placing.
Its been scary how correct you have been with your views, especially around sweetbiotix. I'm astonished a ceo would behave as he has and not expect it to come back and bite. Is soh going through a Biden period? Is the chair running the company?
I don't anyone with eyes can conclude you guys have reported accurately and not allowed the sponsorship to sway you. Its soh integrity thats questionable.
Absolutely spot on — your analysis couldn't be more incisive. Rebuilding credibility in the markets is a Herculean task at the best of times, but when there's compelling evidence of "serial lies and deception," it becomes practically insurmountable. Trust, once shattered, rarely glues back together cleanly — especially not under the stewardship of a CEO who seems, at best, to be making strategic decisions with the acuity of a distracted raccoon.
Choosing to turn on ShareProphets and Lemming Investor — both of whom, despite their occasionally acerbic style, have proven themselves to offer far more balanced and well-researched commentary than anything issuing from the company’s own press releases — is not just counterproductive, it borders on the delusional. It’s a move so misjudged it suggests either panicked deflection or outright incompetence. Either way, the Board's silence only amplifies the growing suspicion that they're running from engagement because they can't withstand scrutiny.
Frankly, if OPTI has any hope of dragging itself out of this mire, meaningful engagement with sceptical voices like ShareProphets or Lemming Investor isn’t optional — it’s essential. Whether it’s the current crop of directors or a completely new broom remains to be seen, but what’s certain is the current approach leads nowhere good.
As for that perennial carrot — the "big contract" that’s supposedly always just around the corner — forgive the cynicism, but 12 years of vapid promises have diluted that hope to homeopathic levels. It's bordering on absurd.
And yes, the Sweetbiotix saga — a supposedly flagship product with not so much as a photograph to prove it exists. No samples, no real-world application, no substantiating detail. If the company can’t even muster the PR basics to showcase a physical product, then what exactly are they doing? The AGM — if and when it ever appears — needs to be less about slides and slogans, and more about receipts and results.